{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:58:32Z","timestamp":1785207512574,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.14310\/horm.2002.1685","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T18:03:56Z","timestamp":1468087436000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cabergoline treatment for recurrent Cushing\u2019s disease during pregnancy"],"prefix":"10.1007","volume":"15","author":[{"given":"Afif","family":"Nakhleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Saiegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Reut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sheikh","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit Wirsansky","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Shechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"15030453_CR1","first-page":"3083","volume":"83","author":"J Lado-Abeal","year":"1998","unstructured":"Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, et al, 1998 Menstrual abnormalities in women with Cushing\u2019s disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 83: 3083.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR2","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1210\/jc.2004-2361","volume":"90","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK, 2005 Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90: 3077\u20133083.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, et al, 2008 The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 1526\u20131540.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR4","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1210\/jc.2004-2361","volume":"90","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK, 2005 Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90: 3077\u20133083.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR5","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM, et al, 2008 Treatment of adrenocorticotropindependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93: 2454\u20132462.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.12.015","volume":"168","author":"WH Lim","year":"2013","unstructured":"Lim WH, Torpy DJ, Jeffries WS, 2013 The medical management of Cushing\u2019s syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol 168: 1\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"15030453_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/S0140-6736(00)02242-X","volume":"355","author":"AP Prebtani","year":"2000","unstructured":"Prebtani AP, Donat D, Ezzat S, 2000 Worrisome striae in pregnancy. Lancet 355: 1692.","journal-title":"Lancet"},{"key":"15030453_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/pgmj.66.773.221","volume":"66","author":"JA Amado","year":"1990","unstructured":"Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A, 1990 Successful treatment with ketoconazole of Cushing\u2019s syndrome in pregnancy. Postgrad Med J 66: 221\u2013223.","journal-title":"Postgrad Med J"},{"key":"15030453_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/09513599909167552","volume":"13","author":"J Berwaerts","year":"1999","unstructured":"Berwaerts J, Verhelst J, Mahler C, Abs R, 1999 Cushing\u2019s syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecol Endocrinol 13: 175\u2013182.","journal-title":"Gynecol Endocrinol"},{"key":"15030453_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3109\/09513590.2010.521268","volume":"27","author":"M Boronat","year":"2011","unstructured":"Boronat M, Marrero D, L\u00f3pez-Plasencia Y, Barber M, Schamann Y, N\u00f3voa FJ, 2011 Successful outcome of pregnancy in a patient with Cushing\u2019s disease under treatment with ketoconazole during the first trimester of gestation. Gynecol Endocrinol 27: 675\u2013677.","journal-title":"Gynecol Endocrinol"},{"key":"15030453_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1741-4520.2005.00053.x","volume":"45","author":"Z Kazy","year":"2005","unstructured":"Kazy Z, Puho\u2019 E, Czeizel AE, 2005 Population-based case-control study of oral ketoconazole treatment for birth outcomes. Congenit Anom (Kyoto) 45: 5\u20138.","journal-title":"Congenit Anom (Kyoto)"},{"key":"15030453_CR12","first-page":"49","volume":"50","author":"S Leiba","year":"1989","unstructured":"Leiba S, Weinstein R, Shindel B, et al, 1989 The protracted effect of o,p\u2019-DDD in Cushing\u2019s disease and its impact on adrenal morphogenesis of young human embryo. Ann Endocrinol (Paris) 50: 49\u201353.","journal-title":"Ann Endocrinol (Paris)"},{"key":"15030453_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/jc.2012-2839","volume":"98","author":"L Tripto-Shkolnik","year":"2013","unstructured":"Tripto-Shkolnik L, Blumenfeld Z, Bronshtein M, Salmon A, Jaffe A, 2013 Pregnancy in a patient with adrenal carcinoma treated with mitotane: A case report and review of literature. J Clin Endocrinol Metab 98: 443\u2013447.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR14","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1210\/jc.2003-030837","volume":"89","author":"R Pivonello","year":"2004","unstructured":"Pivonello R, Ferone D, de Herder WW, et al, 2004 Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab 89: 2452\u20132462.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1210\/jc.2008-1533","volume":"94","author":"R Pivonello","year":"2009","unstructured":"Pivonello R, De Martino MC, Cappabianca P, et al, 2009 The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab 94: 223\u2013230.","journal-title":"J Clin Endocrinol Metab"},{"key":"15030453_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/EJE-10-0382","volume":"163","author":"A Godbout","year":"2010","unstructured":"Godbout A, Manavela M, Danilowicz K, Beauregard H, Bruno OD, Lacroix A, 2010 Cabergoline monotherapy in the long-term treatment of Cushing\u2019s disease. Eur J Endocrinol 163: 709\u2013716.","journal-title":"Eur J Endocrinol"},{"key":"15030453_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.1982.03320360039028","volume":"247","author":"I Turkalj","year":"1982","unstructured":"Turkalj I, Braun P, Krupp P, 1982 Surveillance of bromocriptine in pregnancy. JAMA 247: 1589\u20131591.","journal-title":"JAMA"},{"key":"15030453_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/BF01727477","volume":"65","author":"P Krupp","year":"1987","unstructured":"Krupp P, Monka C, 1987 Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 65: 823\u2013827.","journal-title":"Klin Wochenschr"},{"key":"15030453_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1185\/03007998609110437","volume":"10","author":"C Weil","year":"1986","unstructured":"Weil C, 1986 The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review. Current Medical Research and Opinion 10: 172\u2013195.","journal-title":"Current Medical Research and Opinion"},{"key":"15030453_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","volume":"68","author":"A Colao","year":"2008","unstructured":"Colao A, Abs R, B\u00e1rcena DG, Chanson P, Paulus W, Kleinberg D, 2008 Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clin Endocrinol (Oxf) 68: 66\u201371.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15030453_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","volume":"73","author":"M Lebbe","year":"2010","unstructured":"Lebbe M, Hubinont C, Bernard P, Maiter D, 2010 Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol 73: 236\u2013242.","journal-title":"Clin Endocrinol"},{"key":"15030453_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","volume":"13","author":"G Stalldecker","year":"2010","unstructured":"Stalldecker G, Mallea-Gil MS, Guitelman M, 2010 Effects of cabergoline on pregnancy and embryo-fetal development: Retrospective study on 103 pregnancies and a review of the literature. Pituitary 13: 345\u2013350.","journal-title":"Pituitary"},{"key":"15030453_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12020-014-0334-7","volume":"47","author":"A Glezer","year":"2014","unstructured":"Glezer A, Bronstein MD, 2014 Prolactinomas, cabergoline, and pregnancy. Endocrine 47: 64\u201369.","journal-title":"Endocrine"},{"key":"15030453_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/AOG.0b013e31829e398a","volume":"122","author":"I Woo","year":"2013","unstructured":"Woo I, Ehsanipoor RM, 2013 Cabergoline therapy for cushing disease throughout pregnancy. Obstet Gynecol 122: 485\u2013487.","journal-title":"Obstet Gynecol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1685\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:39:42Z","timestamp":1739115582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["15030453"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1685","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"18 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}